22 May 2013
Keywords: emea, accepts, otsuka, tolvaptan, maa, pharmaceutical, europe
Article | 03 March 2008
Otsuka Pharmaceutical Europe, part of the Japanese Otsuka group, says
that the European Medicines Agency (EMEA) has accepted a Marketing
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
21 May 2013
© 2013 thepharmaletter.com